Beijing, China, May 18 2023 – In May 2023, the Mona Lisa Robotic Prostate Puncture System, a product of MicroPort® MedBot®, was granted market registration by the National Medical Products Administration (NMPA), becoming the first domestically certified prostate puncture robot in the field of urology. The product has revolutionized traditional manual puncture methods and advanced clinical precision puncture through intelligent navigation and positioning systems. This marks a significant breakthrough and progress in prostate biopsy puncture in China, filling the gap in the domestic market and providing more medical options and better conditions for patients in need of prostate biopsy puncture.
